U.S. markets closed

PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.16+1.06 (+1.86%)
At close: 4:00PM EST

58.16 0.00 (0.00%)
After hours: 4:54PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/27/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
3.90B3.17B3.41B2.80B2.97B
Enterprise Value 3
3.17B3.01B3.13B2.11B2.58B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
10.259.349.548.559.05
Price/Book (mrq)
7.635.546.454.714.48
Enterprise Value/Revenue 3
8.8425.4441.6130.9626.74
Enterprise Value/EBITDA 6
-10.72-204.64-18.89-21.65-50.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.00
52-Week Change 310.08%
S&P500 52-Week Change 326.90%
52 Week High 370.82
52 Week Low 330.79
50-Day Moving Average 361.53
200-Day Moving Average 357.12

Share Statistics

Avg Vol (3 month) 3517.95k
Avg Vol (10 day) 3628.74k
Shares Outstanding 568.24M
Float 63.7M
% Held by Insiders 12.91%
% Held by Institutions 1106.46%
Shares Short (Feb 11, 2021) 44.01M
Short Ratio (Feb 11, 2021) 47.74
Short % of Float (Feb 11, 2021) 46.03%
Short % of Shares Outstanding (Feb 11, 2021) 45.88%
Shares Short (prior month Jan 14, 2021) 44.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -115.07%
Operating Margin (ttm)-90.23%

Management Effectiveness

Return on Assets (ttm)-11.21%
Return on Equity (ttm)-81.42%

Income Statement

Revenue (ttm)380.77M
Revenue Per Share (ttm)5.77
Quarterly Revenue Growth (yoy)23.20%
Gross Profit (ttm)-62.22M
EBITDA -300.08M
Net Income Avi to Common (ttm)-438.16M
Diluted EPS (ttm)-6.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)15.69
Total Debt (mrq)420.44M
Total Debt/Equity (mrq)87.23
Current Ratio (mrq)4.44
Book Value Per Share (mrq)6.91

Cash Flow Statement

Operating Cash Flow (ttm)-194.07M
Levered Free Cash Flow (ttm)-168.58M